Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

8.02
Delayed Data
As of Jun 29
 +0.24 / +3.08%
Today’s Change
6.60
Today|||52-Week Range
10.70
-18.16%
Year-to-Date

Today’s Trading

Previous close7.78
Today’s open7.86
Day’s range7.76 - 8.14
Volume61,504
Average volume (3 months)49,643
Market cap$176.7M
Dividend yield--
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-19.44%
Earnings growth (next 5 years)+1.50%
Revenue growth (last year)+6.98%
P/E ratio--
Price/Sales4.53
Price/Book1.29

Competitors

 Today’s
change
Today’s
% change
AKTXAkari Therapeutics P...0.000.00%
OSIROsiris Therapeutics ...-0.18-3.40%
QUREUniqure NV-0.30-4.07%
PFNXPfenex Inc+0.61+7.78%
Data as of 06/29/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)$0.07
Annual revenue (last year)$50.4M
Annual profit (last year)$6.7M
Net profit margin13.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Chief Financial Officer &
Vice President
Oren Bryan
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts

Partner Offers

Search for Jobs